ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,258.61
0.00%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,644.71
0.47%
Brent Oil
72.545
0.13%
Bitcoin
93,167.96
1.30%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Panbela Therapeutics Inc (QB) (PBLA)

  7. Panbela Therapeutics Inc (QB) (PBLA) News

Panbela Therapeutics (QB) (PBLA)

Panbela Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PBLA
DateTimeSourceHeadlineSymbolCompany
19/11/202423:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBLAPanbela Therapeutics Inc (QB)
18/11/202422:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
18/11/202422:04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
18/11/202422:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
18/11/202422:02Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
18/11/202422:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
18/11/202422:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
18/11/202421:59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
18/11/202421:16Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (QB)
15/11/202411:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
15/11/202411:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
15/11/202411:12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
15/11/202411:09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
15/11/202411:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
15/11/202411:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
14/11/202421:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PBLAPanbela Therapeutics Inc (QB)
14/11/202421:12Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202423:40Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipUSOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202423:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202413:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202413:26Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202413:26Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202413:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202413:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202413:24Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
29/10/202413:24Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:PBLAPanbela Therapeutics Inc (QB)
28/10/202421:16Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (QB)
03/10/202420:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBLAPanbela Therapeutics Inc (QB)
03/10/202420:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PBLAPanbela Therapeutics Inc (QB)
27/09/202420:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PBLAPanbela Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:PBLA

Your Recent History

FTSE
E3X201030
FTSEurofirst 300 Pharmac...
LSE
XAXJ
X Acasia Ej Esg
BIT
US10C
Amundi US Treasury Bond ...
COIN
STRATUSD
Stratis
BOV
FRRN6BF
Rumo Malha Norte PNB
BOV
TKNO3F
TEKNO ON
DOWI
DJIMIN
DJ Islamic Market India ...
BIT
P1EYW7
BNP Paribas Issuance
FX
NADXOF
NAD vs XOF
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £2132.64 only £853.06